APTINYX INC's ticker is APTX and the CUSIP is 03836N103. A total of 64 filers reported holding APTINYX INC in Q1 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $10,138 | -79.6% | 81,232 | -53.4% | 0.00% | – |
Q4 2022 | $49,706 | -26.9% | 174,225 | -5.6% | 0.00% | – |
Q3 2022 | $68,000 | -46.5% | 184,525 | -18.9% | 0.00% | – |
Q2 2022 | $127,000 | +47.7% | 227,487 | +497.6% | 0.00% | – |
Q1 2022 | $86,000 | -30.1% | 38,066 | -17.4% | 0.00% | – |
Q4 2021 | $123,000 | +141.2% | 46,102 | +110.5% | 0.00% | – |
Q3 2021 | $51,000 | -66.0% | 21,900 | -58.8% | 0.00% | – |
Q2 2021 | $150,000 | -92.5% | 53,100 | -92.1% | 0.00% | -100.0% |
Q1 2021 | $2,010,000 | +34.3% | 670,111 | +54.9% | 0.01% | +25.0% |
Q4 2020 | $1,497,000 | +209.9% | 432,635 | +202.9% | 0.00% | +100.0% |
Q3 2020 | $483,000 | +24.5% | 142,848 | +53.4% | 0.00% | 0.0% |
Q2 2020 | $388,000 | +60.3% | 93,118 | -16.8% | 0.00% | 0.0% |
Q1 2020 | $242,000 | -41.3% | 111,975 | -7.0% | 0.00% | +100.0% |
Q4 2019 | $412,000 | -29.1% | 120,382 | -27.7% | 0.00% | -50.0% |
Q3 2019 | $581,000 | -15.8% | 166,576 | -19.4% | 0.00% | 0.0% |
Q2 2019 | $690,000 | +48.4% | 206,728 | +79.9% | 0.00% | 0.0% |
Q1 2019 | $465,000 | – | 114,911 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 3,290,079 | $1,836,000 | 1.19% |
ADAMS STREET PARTNERS LLC | 5,395,996 | $3,010,000 | 0.78% |
Bain Capital Life Sciences Investors, LLC | 8,891,758 | $4,961,000 | 0.58% |
Artal Group S.A. | 6,116,493 | $3,412,000 | 0.18% |
Frazier Life Sciences Management, L.P. | 1,883,244 | $1,051,000 | 0.10% |
NORTHWESTERN UNIVERSITY | 109,280 | $61,000 | 0.06% |
DCF Advisers, LLC | 48,529 | $27,000 | 0.02% |
Meridian Wealth Management, LLC | 192,000 | $107,000 | 0.01% |
Orbimed Advisors | 538,500 | $300,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 157,641 | $88,000 | 0.00% |